Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Safety and Efficacy of Atorvastatin on Xanthoma in Alagille Syndrome

NCT05488067 is registered in ClinicalTrials.gov with Children's Hospital of Fudan University as lead sponsor.

NCT NCT05488067
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05488067 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Safety and Efficacy of Atorvastatin on Xanthoma in Alagille Syndrome
Lead sponsor
Children's Hospital of Fudan University
Phase
Phase 4
Overall status
Completed
Start date
March 22, 2022
Completion date
August 1, 2024
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alagille syndrome, atorvastatin, xanthoma